← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Vaxgen, Inc.
Brisbane, CA
$3,661,751
Total funding
4
Grants
Funding mix
By agency
NIH$3,661,751 · 4
By mechanism
R44$3,285,306 · 2
R43$376,445 · 1
N01$0 · 1
Investigators at Vaxgen, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Vaccines Designed From Analysis of Recent HIV Infections$1,019,667
R44 · FY2003 · AI
Vaccines Designed From Analysis of Recent HIV Infections$924,689
R44 · FY2004 · AI
SUBTYPE C HIV ANTIGEN: MULTIVALENT &PRIME-BOOST REGIMEN$495,975
R44 · FY2002 · AI
SUBTYPE C HIV ANTIGEN: MULTIVALENT &PRIME-BOOST REGIMEN$484,975
R44 · FY2001 · AI
Correlates of Protection Against HIV-1 Infection$376,445
R43 · FY2004 · AI
Vaccines Designed From Analysis of Recent HIV Infections$210,000
R44 · FY2002 · AI
SUBTYPE C HIV ANTIGEN: MULTIVALENT &PRIME-BOOST REGIMEN$150,000
R44 · FY2000 · AI
HIV VACCINE PRODUCTION$0
N01 · FY2000 · AI